Profil
Vijay Shreedhar served as the Chief Commercial Officer at Adamas Pharmaceuticals LLC from 2019 to 2021.
Prior to this, he earned a doctorate degree from The University of Texas at Austin and an MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Vijay Shreedhar
| Sociétés | Poste | Fin |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24/11/2021 |
Formation de Vijay Shreedhar
| The University of Texas at Austin | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |